Literature DB >> 2089269

The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine.

C L Eastman1, T R Guilarte.   

Abstract

Previous studies have indicated that the generation of H2O2 may be a key step in the mechanism mediating the in vitro cytotoxicity of 3-hydroxykynurenine (3HK). An exposure protocol resulting in a delayed toxicity was utilized in order to further examine the role of H2O2 in the in vitro toxicity of 3HK in a neural hybrid cell line. 3HK-induced cell lysis was significantly attenuated by administration of catalase after termination of 3HK exposure and was abolished when intracellular peroxidase activity was elevated by pretreatment of cultures with horseradish peroxidase. In addition, a dose-dependent attenuation of 3HK toxicity was observed when cultures were exposed to 3HK in the presence of the iron chelator, desferrioxamine (DFO). Pretreatment with DFO also resulted in a significant attenuation of 3HK toxicity. These data suggest a direct role for H2O2 and metal ions in the cytotoxic action of 3HK and indicate that cell lysis results from the intracellular accumulation of toxic levels of H2O2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2089269     DOI: 10.1007/BF01101711

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

Authors:  H KEBERLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

Review 2.  Role of metal ions in oxidant cell injury.

Authors:  O Cantoni; M Fumo; F Cattabeni
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

3.  Some effects of dietary vitamin B 6 deficiency on -aminobutyric acid metabolism in developing rat brain.

Authors:  R A Bayoumi; W R Smith
Journal:  J Neurochem       Date:  1972-08       Impact factor: 5.372

Review 4.  Transition metals as catalysts of "autoxidation" reactions.

Authors:  D M Miller; G R Buettner; S D Aust
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

5.  Increased concentrations of 3-hydroxykynurenine in vitamin B6 deficient neonatal rat brain.

Authors:  T R Guilarte; H N Wagner
Journal:  J Neurochem       Date:  1987-12       Impact factor: 5.372

6.  Enhancement of high affinity gamma-aminobutyric acid receptor binding in cerebellum of pyridoxine-deficient rat.

Authors:  C S Paulose; K Dakshinamurti
Journal:  Neurosci Lett       Date:  1984-08-10       Impact factor: 3.046

7.  Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line.

Authors:  C L Eastman; T R Guilarte
Journal:  Brain Res       Date:  1989-08-28       Impact factor: 3.252

8.  Effect of vitamin B-6 nutrition on the levels of dopamine, dopamine metabolites, dopa decarboxylase activity, tyrosine, and GABA in the developing rat corpus striatum.

Authors:  T R Guilarte
Journal:  Neurochem Res       Date:  1989-06       Impact factor: 3.996

9.  Brain cell alterations suggesting premature aging induced by dietary deficiency of vitamin B6 and/or copper.

Authors:  E J Root; J B Longenecker
Journal:  Am J Clin Nutr       Date:  1983-04       Impact factor: 7.045

10.  Kynurenines and seizures.

Authors:  I P Lapin
Journal:  Epilepsia       Date:  1981-06       Impact factor: 5.864

View more
  38 in total

1.  Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis.

Authors:  Patricia A Zunszain; Christoph Anacker; Annamaria Cattaneo; Shanas Choudhury; Ksenia Musaelyan; Aye Mu Myint; Sandrine Thuret; Jack Price; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2011-11-09       Impact factor: 7.853

2.  Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine.

Authors:  S Okuda; N Nishiyama; H Saito; H Katsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 3.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

4.  An investigation of the activities of 3-hydroxykynureninase and kynurenine aminotransferase in the brain in Huntington's disease.

Authors:  S J Pearson; A Meldrum; G P Reynolds
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 5.  Where does a migraine attack originate? In the brainstem.

Authors:  J Tajti; D Szok; Á Párdutz; B Tuka; A Csáti; A Kuris; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

6.  Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists.

Authors:  W M H Behan; T W Stone
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.

Authors:  Tomasz Kocki; Sebastian Wnuk; Renata Kloc; Janusz Kocki; Björn Owe-Larsson; Ewa M Urbanska
Journal:  J Neural Transm (Vienna)       Date:  2011-06-10       Impact factor: 3.575

Review 8.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

9.  5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones.

Authors:  Andrew J Smith; Robert A Smith; Trevor W Stone
Journal:  Neurotox Res       Date:  2009-03-04       Impact factor: 3.911

Review 10.  Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.

Authors:  D Zádori; P Klivényi; E Vámos; F Fülöp; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2009-07-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.